Lexaria Bioscience Corp. Warrant

$2.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 2:30 PM UTC today

Why Robinhood?

You can watch LEXXW and buy or sell other stocks, options, and ETFs commission-free!

About LEXXW

Lexaria Bioscience Corp. is a proprietary drug delivery technology company. Its technology DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company's technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH increases bio-absorption, reduces time of onset, and masks unwanted tastes for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a tobacco producer for the development of smokeless, oral-based nicotine products. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada. The listed name for LEXXW is Lexaria Bioscience Corp. Warrant.

CEO
Christopher A. Bunka
Employees
—
Headquarters
Kelowna, British Columbia
Founded
2004
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
23.92K
High Today
$2.00
Low Today
$2.00
Open Price
$2.00
Volume
0.00
52 Week High
$4.22
52 Week Low
$0.60

You May Also Like

CRU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure